First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine

Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis

(2021) Maria Pia Sormani et al.   ANNALS OF NEUROLOGY

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

(2021) Anat Achiron et al.   Multiple Sclerosis Journal

Vaccine Hesitancy in Patients With Multiple Sclerosis

(2021) Lara Diem et al.   Neurology-Neuroimmunology & Neuroinflammation

COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies

(2021) Afagh Garjani et al.   Multiple Sclerosis and Related Disorders

COVID-19-associated acute necrotizing myelitis

(2020) Javier Sotoca et al.   Neurology-Neuroimmunology & Neuroinflammation

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

(2020) Merryn Voysey et al.   LANCET

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

A large case-control study on vaccination as risk factor for multiple sclerosis

(2019) Alexander Hapfelmeier et al.   NEUROLOGY